LLY Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio39.47Forward 30.67
EPS (TTM)$28.17169.9% YoY
Profit margin35.0%HEALTHCARE
Market cap$991.62BMega cap
Wall Street coverage
$1,215.79median target· current $885.99 (+37.2%)31 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 30.67
- PEG ratio
- 1.49
- P/B
- 31.78
- P/S (TTM)
- 13.72
- EV/EBITDA
- 28.43
Profitability & growth
- ROE (TTM)
- 107.5%
- Operating margin
- 49.4%
- Revenue growth YoY
- 55.5%
- Dividend yield
- 0.6%
- Beta
- 0.52
Last earnings
Apr 30, 2026 · Estimate $6.79 · Reported $8.55
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
1 article · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Eli Lilly and Company
Company profileEli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Classification
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- LILLY CORPORATE CENTER, INDIANAPOLIS, IN
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$991.62B
Shares outstanding$891.7M
52W high$1,182.73
52W low$619.40
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent